Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720687 | 0.77 | — | — | |
| SCHEMBL993000 | 0.71 | — | — | |
| SCHEMBL3628017 | 0.71 | — | — | |
| SCHEMBL15212489 | 0.71 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL15212373 | 0.71 | TSHR (0.30) | ALDH1A1 | |
| SCHEMBL15212529 | 0.71 | ALDH1A1 (0.30) | ALDH1A1 | |
| Tetrylammonium SCHEMBL1996794 | 0.71 | TSHR (0.47) | ALDH1A1 | |
| SCHEMBL25345297 | 0.69 | CA1 (0.31) | — | |
| SCHEMBL16758707 | 0.69 | CA1 (0.42) | — | |
| Lithium Ion SCHEMBL1997803 | 0.69 | CA1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148443-B2 | Oxonium and sulfonium salts | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-04-03 | — | — | US | disclosed |
| US-20110034698-A1 | Oxonium And Sulfonium Salts | IGNATYEV NIKOLAI MYKOLA | 2011-02-10 | — | — | US | disclosed |
| US-7842804-B2 | Ionic salts comprising pyrrolidinium, triazolinium, piperidinium or morpholinium cations and alkyltrifluorophosphate anions | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-11-30 | — | — | US | disclosed |
| US-20090036628-A1 | OXONIUM AND SULFONIUM SALTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1979361-A2 | OXONIUM AND SULFONIUM SALTS | Merck Patent GmbH (DE) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007087949-A2 | OXONIUM AND SULFONIUM SALTS | MERCK PATENT GMBH (DE) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034698-A1 | Oxonium And Sulfonium Salts | PRDX2, SCO2, SFXN1 | ALDH1A1 4525/4885 |
| US-20090036628-A1 | OXONIUM AND SULFONIUM SALTS | SCO2, PRDX2, SFXN1 | ALDH1A1 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.